

|
Transgene is a fully integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Our expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.
Four products are currently in clinical development: TG4010, JX594/TG6006, TG4001 and TG4040 in phase II trials.
Transgene has concluded strategic agreements with two pharmaceutical companies... >>> READ MORE
|
December 21, 2011
Transgene and Jennerex Announce First Patient Treated
December 16, 2011
Transgene and the French League against Cancer Enter Partnership
|
PUBLICATIONS
|
|